Cargando…

Downregulation of STOX1 is a novel prognostic biomarker for glioma patients

Storkhead box 1 (STOX1) is a winged helix transcription factor structurally and functionally related to the forkhead family of transcription factors. Recent studies have highlighted its role in the central nervous system and revealed hints in the development of glioma. However, the expression profil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Fei-qin, Jin, Lei, Wang, Yan-ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546287/ https://www.ncbi.nlm.nih.gov/pubmed/34722888 http://dx.doi.org/10.1515/biol-2021-0119

Ejemplares similares

Investigation of the STOX1 polymorphism on lumbar disc herniation
por: Yang, Xuejun, et al.
Publicado: (2019)

STOX2 but not STOX1 is differentially expressed in decidua from pre-eclamptic women: data from the Second Nord-Trøndelag Health Study
por: Fenstad, M.H., et al.
Publicado: (2010)

Endothelial cell dysfunction and cardiac hypertrophy in the STOX1 model of preeclampsia
por: Ducat, Aurélien, et al.
Publicado: (2016)

Long-term cardiovascular disorders in the STOX1 mouse model of preeclampsia
por: Miralles, Francisco, et al.
Publicado: (2019)

STOX1 deficiency is associated with renin-mediated gestational hypertension and placental defects
por: Parchem, Jacqueline G., et al.
Publicado: (2021)

The effect of maternal NODAL on STOX1 expression in extravillous trophoblasts is mediated by IGF1
por: Visser, Allerdien, et al.
Publicado: (2018)

ARL3 is downregulated and acts as a prognostic biomarker in glioma
por: Wang, Yulin, et al.
Publicado: (2019)

Modeling Preeclampsia In Vitro: Polymorphic Variants of STOX1-A/B Genes Can Downregulate CD24 in Trophoblast Cell Lines
por: Sammar, Marei, et al.
Publicado: (2022)

Maternal Nodal inversely affects NODAL and STOX1 expression in the fetal placenta
por: Thulluru, Hari Krishna, et al.
Publicado: (2013)

Molecular Mechanisms of Trophoblast Dysfunction Mediated by Imbalance between STOX1 Isoforms
por: Ducat, Aurélien, et al.
Publicado: (2020)

STOX1 Overexpression in Choriocarcinoma Cells Mimics Transcriptional Alterations Observed in Preeclamptic Placentas
por: Rigourd, Virginie, et al.
Publicado: (2008)

Transcription Factor STOX1A Promotes Mitotic Entry by Binding to the CCNB1 Promotor
por: van Abel, Daan, et al.
Publicado: (2012)

ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma
por: Liu, Zhen-Yuan, et al.
Publicado: (2023)

STOX1: Key Player in Trophoblast Dysfunction Underlying Early Onset Preeclampsia with Growth Retardation
por: van Dijk, Marie, et al.
Publicado: (2011)

SFRS7-Mediated Splicing of Tau Exon 10 Is Directly Regulated by STOX1A in Glial Cells
por: van Abel, Daan, et al.
Publicado: (2011)

Noncoding RNA-regulated gain-of-function of STOX2 in Finnish pre-eclamptic families
por: Oudejans, Cees BM, et al.
Publicado: (2016)

Inhibition of FGF and TGF-β Pathways in hESCs Identify STOX2 as a Novel SMAD2/4 Cofactor
por: Renz, Peter F., et al.
Publicado: (2020)

Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance
por: Wang, Lingling, et al.
Publicado: (2016)

Alpha-1 microglobulin as a potential therapeutic candidate for treatment of hypertension and oxidative stress in the STOX1 preeclampsia mouse model
por: Erlandsson, Lena, et al.
Publicado: (2019)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

BCL7A as a novel prognostic biomarker for glioma patients
por: Liu, Junhui, et al.
Publicado: (2021)

TREM1 as a novel prognostic biomarker and tumor immune microenvironment evaluator in glioma
por: Lu, Qin, et al.
Publicado: (2023)

Stanniocalcin 1 is a prognostic biomarker in glioma
por: Luo, Weijian, et al.
Publicado: (2020)

ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Effect of STOX1 on recurrent spontaneous abortion by regulating trophoblast cell proliferation and migration via the PI3K/AKT signaling pathway
por: Li, Zhifang, et al.
Publicado: (2018)

VMP1, a novel prognostic biomarker, contributes to glioma development by regulating autophagy
por: Lin, Wanzun, et al.
Publicado: (2021)

Comparative genetic, proteomic and phosphoproteomic analysis of C. elegans embryos with a focus on ham-1/STOX and pig-1/MELK in dopaminergic neuron development
por: Offenburger, Sarah-Lena, et al.
Publicado: (2017)

Prognostic and Predictive Biomarkers in Gliomas
por: Śledzińska, Paulina, et al.
Publicado: (2021)

SPRED1 Is Downregulated and a Prognostic Biomarker in Adult Acute Myeloid Leukemia
por: Zhang, Rui, et al.
Publicado: (2020)

IKBIP is a novel EMT-related biomarker and predicts poor survival in glioma
por: Yang, Ying, et al.
Publicado: (2021)

BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
por: Wu, Yu, et al.
Publicado: (2019)

Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas
por: Li, Junsheng, et al.
Publicado: (2022)

Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients
por: Li, Hainan, et al.
Publicado: (2021)

MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma
por: Yang, Shu, et al.
Publicado: (2022)

TRIM6: An Upregulated Biomarker with Prognostic Significance and Immune Correlations in Gliomas
por: Guo, Jianrong, et al.
Publicado: (2023)

HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas
por: Zhu, Huaxin, et al.
Publicado: (2023)

BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma
por: Yang, Ying, et al.
Publicado: (2021)

F11R Is a Novel Monocyte Prognostic Biomarker for Malignant Glioma
por: Pong, Winnie W., et al.
Publicado: (2013)

miR-30a targets STOX2 to increase cell proliferation and metastasis in hydatidiform moles via ERK, AKT, and P38 signaling pathways
por: Guo, Zhenzhen, et al.
Publicado: (2022)

A Novel Immune-Related Prognostic Biomarker and Target Associated With Malignant Progression of Glioma
por: Zhang, Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v4va1r29bsp3mf7f2gaai3qsk6